Details for New Drug Application (NDA): 020404

✉ Email this page to a colleague

NDA 020404 describes AVITA, which is a drug marketed by Mylan Pharms Inc and Rising and is included in two NDAs. It is available from two suppliers. Additional details are available on the AVITA profile page.

The generic ingredient in AVITA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for 020404

Tradename:	AVITA
Applicant:	Mylan Pharms Inc
Ingredient:	tretinoin
Patents:	0

Medical Subject Heading (MeSH) Categories for 020404

Antineoplastic Agents
Keratolytic Agents

Suppliers and Packaging for NDA: 020404

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
AVITA	tretinoin	CREAM;TOPICAL	020404	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	0472-0117	0472-0117-20	1 TUBE in 1 CARTON (0472-0117-20) / 20 g in 1 TUBE
AVITA	tretinoin	CREAM;TOPICAL	020404	NDA AUTHORIZED GENERIC	Actavis Pharma, Inc.	0472-0117	0472-0117-45	1 TUBE in 1 CARTON (0472-0117-45) / 45 g in 1 TUBE

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CREAM;TOPICAL			Strength	0.025%
Approval Date:	Jan 14, 1997	TE:	AB	RLD:	No

Expired US Patents for NDA 020404

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	⤷ Get Started Free	⤷ Get Started Free
Mylan Pharms Inc	AVITA	tretinoin	CREAM;TOPICAL	020404-003	Jan 14, 1997	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.